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Abstract
Background: High-fat diets promote hepatic lipid accumulation. Paradoxically, these diets also induce lipogenic gene
expression in rodent liver. Whether high expression of these genes actually results in an increased flux through the de novo
lipogenic pathway in vivo has not been demonstrated.
Methodology/Principal Findings: To interrogate this apparent paradox, we have quantified de novo lipogenesis in C57Bl/6J
mice fed either chow, a high-fat or a n-3 polyunsaturated fatty acid (PUFA)-enriched high-fat diet. A novel approach based
on mass isotopomer distribution analysis (MIDA) following 1-
13C acetate infusion was applied to simultaneously determine
de novo lipogenesis, fatty acid elongation as well as cholesterol synthesis. Furthermore, we measured very low density
lipoprotein-triglyceride (VLDL-TG) production rates. High-fat feeding promoted hepatic lipid accumulation and induced the
expression of lipogenic and cholesterogenic genes compared to chow-fed mice: induction of gene expression was found to
translate into increased oleate synthesis. Interestingly, this higher lipogenic flux (+74 mg/g/h for oleic acid) in mice fed the
high-fat diet was mainly due to an increased hepatic elongation of unlabeled palmitate (+66 mg/g/h) rather than to
elongation of de novo synthesized palmitate. In addition, fractional cholesterol synthesis was increased, i.e. 5.860.4% vs.
8.160.6% for control and high fat-fed animals, respectively. Hepatic VLDL-TG production was not affected by high-fat
feeding. Partial replacement of saturated fat by fish oil completely reversed the lipogenic effects of high-fat feeding: hepatic
lipogenic and cholesterogenic gene expression levels as well as fatty acid and cholesterol synthesis rates were normalized.
Conclusions/Significance: High-fat feeding induces hepatic fatty acid synthesis in mice, by chain elongation and
subsequent desaturation rather than de novo synthesis, while VLDL-TG output remains unaffected. Suppression of lipogenic
fluxes by fish oil prevents from high fat diet-induced hepatic steatosis in mice.
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Introduction
Non-alcoholic fatty liver disease (NAFLD) is one of the
hallmarks of the metabolic syndrome and is strongly associated
with obesity and insulin resistance [1]. NAFLD is characterized by
the accumulation of hepatic triglycerides (TGs) resulting from an
imbalance between uptake, synthesis, export and oxidation of fatty
acids [2]. NAFLD may progress to non-alcoholic steatohepatitis
(NASH) in response to a ‘second hit’ [3]. Although high fat diets
consistently induce hepatic steatosis and insulin resistance in
humans and laboratory animals [4–6], the mechanisms underlying
this high fat diet-induced lipid accumulation are largely unknown.
Interestingly, high-fat feeding has been reported to result in a
paradoxical increase in the expression of lipogenic genes in mouse
liver. This was suggested to be mediated via peroxisome
proliferator activated receptor gamma co-activator 1 beta (PGC-
1ß) co-activation of the lipogenic transcription factor sterol
regulatory element binding protein 1c (SREBP-1c) [7]. Ablation
or suppression of critical genes controlling hepatic lipogenesis [8–
11] counteracts the development of hepatic steatosis in animals
receiving high-fat diets. Furthermore, partial substitution of the fat
within a high-fat diet for fish oil, a source of n-3 polyunsaturated
fatty acids (PUFA), abrogates hepatic lipid accumulation [6]. An
inhibition of the activity of lipogenic transcription factors and the
subsequent suppression of their target genes by n-3 PUFA [12] is
considered to contribute to the protective effects of fish oil.
Although these observations suggest that the activity of lipogenic
enzymes is related to the degree of high fat diet-induced hepatic
steatosis, an increased de novo fatty acid synthesis appears
counterintuitive under conditions of a high dietary fatty acid load.
Accurate quantification of fatty acid synthesis and its contribu-
tion to hepatic lipid content has not been reported. Furthermore,
the relative contributions of de novo lipogenesis (i.e., synthesis from
acetyl-CoA moieties) and chain elongation of fatty acids to hepatic
lipid synthesis in vivo in mice are currently unknown. In addition,
PLoS ONE | www.plosone.org 1 June 2009 | Volume 4 | Issue 6 | e6066the relationships between high-fat feeding, fatty acid synthesis and
hepatic VLDL-TG production are of particular interest because of
the reported alterations in plasma (VLDL)-TG levels following
Srebp1 and Pgc-1ß overexpression and knockdown in mice [7,13].
We therefore determined in vivo rates of fatty acid and cholesterol
synthesis in relation to VLDL-TG production rates in mice fed low-
fat laboratory chow, a high-fat diet containing beef fat (rich in
saturated fat), or a diet in which part of the beef fat was replaced by
fish oil. A novel approach based on
13C-acetate incorporation
followed by mass isotopomer distribution analysis (MIDA) enabled
us to quantify the relative contribution of the de novo lipogenic
pathway as well as chain elongation of de novo synthesized and pre-
existing palmitate (C16:0) to stearic acid (C18:0) synthesis and its
subsequent desaturation to oleic (C18:1 n-9) acid. We found that
high-fat feeding indeed increased oleic acid synthesis, however this
was mainly due to chain elongation of pre-existing palmitate rather
than to an increase in de novo lipogenesis. Cholesterol synthesis was
also increased while VLDL-TG secretion remained unaffected.
These metabolic changes contributed to hepatic TG and choles-
terol-ester accumulation. Fish oil reduced both de novo lipogenesis
and chain elongation and normalized hepatic lipid contents.
Results
High-fat feeding induces hepatic lipogenic gene
expression in parallel to lipid accumulation
Mice fed the high-fat and high-fat/fish oil diet had higher
caloric intakes (chow, 12.360.1; high-fat, 17.160.8, high-fat/fish
oil 16.861.0 kcal/day, p,0.05 high-fat vs. chow). At the end of
the dietary period, their body weight were increased compared to
that of chow-fed animals (chow, 28.260.4; high-fat, 30.560.8;
high-fat/fish oil, 33.460.8 g, p,0.05 high-fat vs. chow and high-
fat/fish oil vs. high-fat). This was due to an increased fat mass
(chow, 2.160.1; high-fat, 6.360.5; high-fat/fish oil, 7.660.4% of
total body weight, p,0.05 high-fat vs. chow). Expression of genes
encoding enzymes involved in hepatic fatty acid (Acc, Fas, Scd1,
Elovl6) and TG synthesis (Dgat, Gpat) was induced in mice fed the
high-fat diet compared to animals receiving chow. Furthermore,
Srebp-1c and Pgc-1b expression was higher in these mice as
compared to controls (Figure 1). The increase in lipogenic gene
expression was associated with increases in hepatic TG (chow,
9.261.6; high-fat, 16.462.4 mmol/g, p,0.05) cholesterol ester
(chow, 0.960.2; high-fat, 2.560.2 mmol/g, p,0.05) and free
cholesterol (chow, 6.060.2; high-fat, 7.860.5 mmol/g, p,0.05)
contents in mice fed the high-fat diet. Partial replacement of the
saturated fat within the high-fat diet by n-3 PUFA strongly
suppressed hepatic lipogenic gene expression (Figure 1) and
normalized hepatic TG and cholesterol ester contents (Figure 2A
and 2B) to values observed in chow-fed mice. Hepatic phospho-
lipid contents (Figure 2C and 2D) and liver weights (chow,
0.9660.07; high-fat, 1.0860.04; high-fat/fish oil, 1.0860.03 g)
were similar in all mice. Hepatic fatty acid profiles are shown in
Table 1. The total amount of fatty acids was increased in mice fed
the high-fat diet compared to chow-fed controls due to
accumulation of TG and cholesterol esters. In general, the
contribution of mono-unsaturated fatty acids was increased by
high-fat feeding and desaturation indices were consequently
increased. Fish oil normalized hepatic mono-unsaturated fatty
acid content and the desaturation indices.
High-fat feeding increases hepatic fatty acid synthesis
from chain elongation
To assess whether the accumulation of hepatic lipids in response
to high-fat feeding resulted from an increased de novo fatty acid
synthesis and/or chain elongation of de novo synthesized versus
existing palmitate, we infused [1-
13C]-acetate and applied MIDA
to the measured label distribution patterns of palmitate, stearate
and oleate, assuming that label incorporation was due to de novo
lipogenesis only. The resulting estimations of the acetyl-CoA
precursor pool enrichments are shown in Table 2. Compared to
chow-fed animals, acetyl-CoA pool enrichments were increased in
mice fed the high-fat diet for all fatty acids analyzed. Precursor
pool enrichments were similar in mice fed chow and fish oil. In
general, there was a clear discrepancy in acetyl-CoA pool
enrichments for palmitate (C16:0) and palmitoate (C16:1) on
one hand and stearate (C18:0) and oleate (C18:1) on the other
hand. The precursor pool enrichment calculated for C16-fatty
acids was higher than that calculated to C18-fatty acids. This
indicates that singly labeled fatty acids were high compared to
triple labelled fatty acids. We interpreted this difference as a
reflection of the different synthetic pathways of these fatty acids.
C16-fatty acids are mainly synthesized by de novo lipogenesis, while
C18-fatty acids result from elongation of palmitate. Palmitate can
either be synthesized de novo, or originate from pre-existing sources.
Accordingly, additional single labelled stearate is synthesized from
elongation of pre-existing palmitate with a labelled acetyl-CoA
moiety. This results in an excess contribution of single labelled
molecules in C18-fatty acids over what could be anticipated based
on the contribution of triple labelled molecules originating from
elongation of de novo synthesized palmitate. The precursor pool
enrichment, calculated by MIDA from C18-fatty acids will
consequently be underestimated compared to that calculated from
C16-fatty acids. Therefore, we modified the MIDA algorithms
[14–16] to account for excess single labelled C18-fatty acids, as
described in Materials and Methods.
Compared to chow-fed animals, average fractional and absolute
C16:0 synthesis were increased by high-fat feeding, although the
difference did not reach statistical significance (Figure 3A and 3B).
Figure 1. Hepatic lipogenic gene expressions. Data were
calculated relative to the expression of 18S and normalized for
expression levels of control mice on chow. Srebp-1c, sterol regulatory
element binding protein 1c; Pgc-1b, peroxisome proliferator activated
receptor gamma co-activator 1 beta; Acc, acetyl-CoA carboxylase; Fas,
fatty acid synthase; Elovl6, fatty acid elongase 6; Scd1, stearoyl-CoA
desaturase 1; Dgat, diacylglycerol acyltransferase; Gpat, glycerol-3-
phosphate acyltransferase. White bars represent chow diet; black bars
represent high-fat diet and grey bars represent high-fat/fish oil diet.
Values are given as means6SEM for n=6/7; * p,0.05 high-fat vs. chow;
# p,0.05 high-fat/fish oil vs. high-fat.
doi:10.1371/journal.pone.0006066.g001
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synthesis, and the contributions of de novo synthesis and chain
elongation were similar compared to chow-fed mice (Figure 3C
and 3D). Although high-fat feeding did not affect fractional C18:1
synthesis, the absolute synthesis by elongation of both de novo
synthesized (+300% vs. chow, p,0.05) and pre-existing palmitate
(+213% vs. chow, p,0.05) was increased as a result of the larger
pool size. However, the contribution of elongation of pre-existing
palmitate to the increase in C18:1 synthesis much more
pronounced compared to elongation of de novo synthesized
palmitate (89 vs. 11%) in high-fat fed mice. When the saturated
fat was partially replaced by fish oil, fractional and absolute C16:0
synthesis were both suppressed in high fat-fed mice (266% and
270% vs. high-fat, p,0.05, Figure 3A and 3B). Furthermore, fish
oil inhibited C18:0 synthesis from elongation of both de novo
synthesized and pre-existing palmitate (total absolute C18:0
Figure 2. Hepatic lipid content. A, Hepatic triglyceride content. B,
Hepatic cholesterol ester content. C, Hepatic free cholesterol content. D,
Hepatic phospholipid content. White bars represent chow diet; black
bars represent high-fat diet and grey bars represent high-fat/fish oil
diet. Values are given as means6SEM for n=6/7; * p,0.05 high-fat vs.
chow; # p,0.05 high-fat/fish oil vs. high-fat.
doi:10.1371/journal.pone.0006066.g002
Table 1. Fatty acid composition of experimental diets and
livers.
chow high-fat high-fat/fish oil
Diet (mg/g)
C14:0 0.5 12.2 16.1
C16:0 8.4 92.5 79.5
C16:1 0.7 11.5 18.0
C18:0 3.7 76.3 50.5
C18:1 13.7 133.2 101.0
C18:2 16.9 11.5 9.7
C18:3 1.9 2.9 15.2
C20–22 0.4 4.0 53.3
C16 desaturation index 0.08 0.12 0.18
C18 desaturation index 3.7 1.7 2.0
Liver (mg/g)
C14:0 0.160.0 0.260.0* 0.160.0#
C16:0 7.760.6 9.060.3 8.260.6
C16:1 0.660.1 1.060.1* 0.460.1#
C18:0 4.160.3 4.860.2 5.060.2
C18:1 6.060.4 16.962.1* 6.160.6#
C18:2 7.060.7 2.860.2* 2.960.3
C18:3 0.360.0 0.260.0* 0.260.0
C20–22 8.460.5 9.260.5 11.160.6#
C16 desaturation index 0.0760.00 0.1160.01* 0.0560.00#
C18 desaturation index 1.560.1 3.660.5* 1.260.1#
Values are given as means6SEM for n=6/7.
*p,0.05 high-fat vs. chow.
#p,0.05 high-fat/fish oil vs. high-fat.
doi:10.1371/journal.pone.0006066.t001
Table 2. Acetyl-CoA precursor pool enrichments.
chow high-fat high-fat/fish oil
C16:0 8.860.5 13.060.3* 8.460.3#
C16:1 10.060.8 13.260.6* 10.261.2#
C18:0 5.760.2 8.160.5* 4.460.3#
C18:1 4.560.3 6.760.7* 7.061.0
Values are given as means6SEM for n=5–7 and expressed in percentages.
*p,0.05 high-fat vs. chow.
#p,0.05 high-fat/fish oil vs. high-fat.
doi:10.1371/journal.pone.0006066.t002
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from elongation of de novo synthesized and pre-existing palmitate
was almost completely abolished in fish oil-fed mice (absolute
C18:1 synthesis, 291% and 289% vs. high-fat, p,0.05, Figure 3C
and 3D).
High-fat feeding increases cholesterol synthesis
High-fat feeding resulted in higher mRNA levels for enzymes
involved in cholesterol biosynthesis (i.e. Hmgs and Hmgr) while
expression of Acat1 and Acat2 was not affected (Figure 4A).
Expression of Srebp-2, which encodes a transcriptional regulator of
cholesterol synthesis, was also induced. We therefore determined
fractional cholesterol synthesis in vivo following [1-
13C]-acetate
infusion and MIDA. Again, high-fat feeding increased acetyl-CoA
precursor pool enrichment (chow, 5.360.4; high-fat, 10.260.8%,
p,0.05). Moreover, high-fat feeding increased fractional choles-
terol synthesis compared to chow-fed controls (chow, 5.860.4;
high-fat, 8.160.6%, p,0.05, Figure 4B). Fish oil normalized
mRNA expression of cholesterogenic genes, acetyl-CoA precursor
pool enrichment (high-fat/fish oil: 6.060.4%, p,0.05 vs. high-fat)
and fractional cholesterol synthesis (high-fat/fish oil: 5.660.3%,
p,0.05 vs. high-fat, Figure 4B).
High-fat feeding does not affect hepatic VLDL-TG
secretion
To assess whether high-fat feeding modulated hepatic lipid
secretion, we determined VLDL-TG production rates. Plasma TG
levels prior to Poloxamer-407 injection were somewhat higher in
mice fed the high-fat diet compared to animals fed chow and lower
in fish oil-fed mice (chow, 0.460.0; high-fat, 0.560.0; high-fat/
fish oil 0.360.0 mmol/L, p,0.05 chow vs. high-fat, high-fat vs.
high-fat/fish oil, Figure 5A). High-fat feeding resulted in a slight
statistically non-significant reduction in hepatic VLDL-TG
production compared to chow-fed animals (chow, 16868; high-
fat 15466 mmol/kg/hour). In addition, the relative TG content of
VLDL was decreased at the expense of phospholipids in mice fed
the high-fat diet (Table 3). Calculated size of nascent VLDL was
reduced by high-fat feeding and Western blot analysis revealed
that high-fat feeding increased the relative amount of apoB48-
containing VLDL particles compared to mice fed chow (Table 3).
Fish oil suppressed hepatic VLDL-TG production (11065 mmol/
kg/hour, p,0.05 vs. high-fat, Figure 5A and 5B) and partially
normalized the composition and size of the nascent VLDL
particles to values observed in chow-fed animals (Table 3). In
addition, fish oil partially restored the balance between apoB48
and apoB100-containing particles.
Discussion
The major finding of our study is that the counterintuitive
induction of hepatic lipogenic genes upon high-fat feeding is
paralleled by adaptive remodelling of hepatic fatty acids rather
than to increased de novo lipogenesis. High-fat feeding also
promoted cholesterol synthesis but did not stimulate VLDL-TG
secretion. Consequently, TG and cholesterol esters accumulated in
the livers of high fat-fed mice. Partial replacement of the saturated
Figure 3. Hepatic fatty acid synthesis. A, Fractional palmitate
synthesis from de novo lipogenesis (C16:0*). B, Absolute palmitate
synthesis from de novo lipogenesis (C16:0*). C, Fractional stearate
(C18:0) and oleate (C18:1) synthesis from elongation of de novo
synthesized (C16:0*) and pre-existing (C16:0) palmitate. D, Absolute
stearate (C18:0) and oleate (C18:1) synthesis from elongation of de novo
synthesized (C16:0*) and pre-existing (C16:0) palmitate. White bars
represent chow diet, black bars represent high-fat diet and grey bars
represent high-fat/fish oil diet. Plain bars represent synthesis from
elongation of de novo synthesized palmitate and dashed bars represent
synthesis from elongation of pre-existing palmitate. Absolute synthesis
rates are expressed as micrograms per gram liver per hour. Values are
given as means6SEM for n=5–7; * p,0.05 high-fat vs. chow; # p,0.05
high-fat/fish oil vs. high-fat.
doi:10.1371/journal.pone.0006066.g003
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de novo lipogenesis and chain elongation as well as cholesterol
synthesis.
We applied a novel approach based on in vivo
13C-acetate
incorporation followed by MIDA to determine the contribution of
de novo lipogenesis and chain elongation to the synthesis of three
major hepatic fatty acids. The most commonly used method to
determine hepatic lipogenesis in vivo in experimental animals is by
quantification of the incorporation of
3H from
3H2O into total
hepatic fatty acids. However, this method only provides a rough
estimate of fractional hepatic fatty acid synthesis since
3H2O-
derived label is incorporated into multiple positions in fatty acids
by different metabolic pathways. Our approach provides more
detailed information about the origin of the newly synthesized fatty
acids. We modified the model introduced by Hellerstein and
Neese [14–16] to determine the contributions of chain elongation
of de novo synthesized and pre-existing palmitate to stearate and
oleate synthesis. In the original model, palmitate synthesis is
considered as a 8-step polymerization of acetate units. Infusion of
labelled acetate in vivo will result in its incorporation into fatty
acids. The frequency of label incorporation depends on the
enrichment of the acetate pool, i.e. the precursor pool enrichment.
The newly synthesized fatty acids will either be labelled or
unlabelled. This pool of newly synthesized fatty acids is
subsequently diluted in the existing pool of unlabelled fatty acids.
Thus, due to the synthesis of both labelled and unlabelled fatty
acids, one cannot calculate fractional fatty acid synthesis rates
from the dilution of the labelled fatty acids only. Firstly, the
enrichment of the acetate pool is calculated from the M3/M1 ratio,
which is insensitive towards dilution. Secondly, this precursor pool
Figure 4. Cholesterol metabolism. A, Hepatic cholesterogenic gene expression. Cholesterogenic gene expression levels were calculated relative
to the expression of 18S and normalized for expression levels of control mice on chow. Srebp-2, sterol regulatory element binding protein-2; Hmgs
(cyto), 3-hydroxy-3-methylglutaryl-CoA synthase 1; Hmgr, 3-Hydroxy-3-methylglutaryl-CoA reductase; Acat, acyl-CoA:cholesterol acyltransferase. B,
Fractional synthesis rates. White bars represent chow diet, black bars represent high-fat diet and grey bars represent high-fat/fish oil diet. Values are
given as means6SEM for n=5–7; * p,0.05 high-fat vs. chow; # p,0.05 high-fat/fish oil vs. high-fat.
doi:10.1371/journal.pone.0006066.g004
Lipogenic Flux and Dietary Fat
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frequency of triple labelled fatty acids. This step in the MIDA
actually also accounts for the synthesis of unlabelled fatty acids.
The ratio of the theoretical frequency over the measured
amplitude of a particular fatty acid mass isotopomer subsequently
generates the dilution of the newly synthesized fatty acid. We
applied this procedure to calculate fractional palmitate synthesis,
assuming that this is solely reflects de novo lipogenesis. Next, we
assumed that acetyl-CoA used for elongation of de novo synthesized
and pre-existing palmitate originates from the same pool, i.e. that
the precursor pool enrichment calculated for palmitate equals that
for stearate and oleate. Finally, the mass isotopomer distribution
patterns of stearate and oleate were used to calculate the
contributions of elongation of de novo synthesized and pre-existing
palmitate. Some studies have casted doubt on the homogeneity of
the hepatic acetyl-CoA pool [17,18], which could explain the
difference in pool enrichments in palmitate versus cholesterol
observed in the current study. However, Hellerstein et al., have
shown that the enrichment of the precursor pool for fatty acid
synthesis is very similar to that of acetate residues in acetylated
drugs [19]. Furthermore, inhomogeneous labelling of the hepatic
acetyl-CoA pool has been observed at very high degrees of
labelling, i.e., around 70% [18]. We and others [16,20–22] have
avoided this issue by using protocols that result in a moderate
precursor pool labelling of ,15%.
The high fat diet-induced increase in lipogenic gene expression
observed in this study, confirms earlier reports [7,11]. We now
show that the increase in lipogenic genes does not result in a
significant induction of de novo lipogenesis, hence this pathway
appears to be of minor physiological importance in the
development of hepatic lipid accumulation under conditions of
high-fat feeding. De novo synthesis of palmitic acid was not
significantly increased. Furthermore, the contribution of elonga-
tion of de novo synthesized palmitate to absolute stearate and oleate
synthesis was only minor and represented 20 and 9% of the total
synthesis, respectively in chow-fed animals. A relative decrease in
the contribution of de novo lipogenesis to hepatic TG has recently
also been reported in rats fed a high-fat diet [23]. Moreover, de
novo lipogenesis is not induced upon a short-term dietary fat
challenge in human subjects [24,25]. Palmitate synthesis from de
novo lipogenesis may however have been overestimated in the
current study because we were not able to quantify the
contribution of chain elongation to the synthesis of this fatty acid.
However, because of the relatively low dietary myristic acid
content, we consider this contribution to be of minor importance.
Chain elongation of pre-existing palmitate represented 89% of the
increase in C18:1 synthesis upon high-fat feeding. Another
interesting finding in our study is the observation that partial
eucaloric replacement of saturated fat within the high-fat diet by
fish oil completely abrogated the lipogenic effect. Partial fish oil
replacement was apparently sufficient to normalize lipogenic gene
expression profiles and hepatic steatosis, even under conditions of
inhibited VLDL-TG secretion. The suppressive effect of n-3
PUFA on lipogenic gene expression in liver has been reported in
earlier studies [12], however, the physiological effect of fish oil on
de novo lipogenesis and chain elongation in vivo has not been
investigated before. Our work shows that fish oil not only
counteracts the increase in hepatic chain elongation, but also
suppresses fatty acid synthesis via the de novo lipogenic pathway.
Interestingly, lipid partitioning to TG storage has recently been
suggested to protect the liver from lipotoxicity [26]. Obesity and
insulin resistance result in an increased flux of fatty acids from
adipose tissue towards the liver [2]. If hepatic fatty acid oxidation
is not sufficient to meet its influx, fatty acids may be elongated [27]
and/or re-esterified to prevent their toxic accumulation [28]. On
the other hand, high fat diet-induced steatosis is prevented if
hepatic fatty acid influx is blocked by knockdown of the fatty acid
transporter FATP5 [29]. The increased fatty acid elongation and
subsequent TG synthesis upon high-fat feeding may therefore
Figure 5. Hepatic very low density lipoprotein (VLDL) secre-
tion. A, Plasma TG concentrations and B, VLDL-TG production rates.
White bullets and bars represent chow diet, black bullets and bars
represent high-fat diet and grey bullets and bars represent high-fat/fish
oil diet. Values are given as means6SEM for n=7–8; * p,0.05 high-fat
vs. chow; # p,0.05 high-fat/fish oil vs. high-fat.
doi:10.1371/journal.pone.0006066.g005
Table 3. VLDL composition and calculated size.
chow high-fat high-fat/fish oil
Triglycerides (mol%) 76.860.3 68.061.0* 73.160.4#
Phospholipids (mol%) 17.660.4 26.761.0* 19.060.4#
Cholesterol (mol%) 5.660.3 5.360.2 7.660.2#
Particle diameter (nm) 71.661.3 48.861.7* 64.261.2#
Particle volume (10
5 nm
3) 1.960.1 0.660.1* 1.460.1#
ApoB48 (%) 80659 2 618 6 62#
ApoB100 (%) 20658 611 4 62#
Values are given as means6SEM for n=7–8 for the particle composition and
size data and means6SEM for n=4 for the apolipoprotein B (apoB) abundance.
*p,0.05 high-fat vs. chow.
#p,0.05 high-fat/fish oil vs. high-fat.
doi:10.1371/journal.pone.0006066.t003
Lipogenic Flux and Dietary Fat
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hepatic fatty acid content induces ACAT activity [30,31], thereby
promoting fatty acid esterification to cholesterol, as reflected by
higher hepatic cholesterol-ester contents in high fat-fed mice. As a
consequence, cellular free cholesterol content drops, which, in
turn, provokes a compensatory SREBP-2-mediated induction of
cholesterol synthesis [32,33] that is reflected by an increased
expression of cholesterogenic genes and increased cholesterol
synthesis. Similar adaptive mechanisms leading to cholesterol-ester
accumulation exist when mice that are unable to exert feedback-
inhibition by cellular cholesterol (i.e. Lxra
2/2 mice) are
challenged with dietary cholesterol [34]. Thus, in response to an
increased substrate supply, the liver exerts several adaptive
physiological responses to prevent cytotoxic accumulation of lipid
species. In the current study, the increase in oleate synthesis most
likely reflects the liver’s attempt to safely store saturated fatty acids
as relatively harmless TGs. Palmitate was first elongated into
stearate, which in turn was desaturated to oleate via SCD1 action.
Stearate itself is only minimally present in TGs [34]. Hepatic
SCD1 action actually plays a key role in the partitioning of excess
lipid and enables adequate storage [26]. It has to be noted that the
influx of dietary saturated fatty acids may have been limited, since
we performed the experiments after a 4-hour fast. Under these
conditions, fatty acid influx from adipose tissue probably
dominates. Obesity and insulin resistance [2] may therefore in
fact indirectly result in the increase in hepatic oleate synthesis via
chain elongation of circulating palmitate in high fat-fed mice. It
should however be noted that the lipogenic fluxes maximally
accounted for 15% of the hepatic fatty acid pool. Re-esterification
of circulating fatty acids therefore represents the major pathway
contributing to hepatic TG disposal. The induction of protective
systems upon high-fat feeding is absent in case of partial isocaloric
replacement of the saturated fat by fish oil. In addition to a
profound suppression of lipogenic gene expression [12], such
dietary modulation apparently alters the cellular fate of fatty acids
and their influx into the liver. In this respect, it should be noted
that n-3 PUFA not only promote fatty acid oxidation [35], but also
increase peripheral lipid clearance presumably by enhancing LPL-
activity [36–39]. As a result, fatty acids are sequestered in
extrahepatic tissues, predominantly in adipose stores. Mice fed the
fish-oil containing high-fat diet indeed deposited more fat in their
adipose tissue.
Despite increased substrate availability and elevated hepatic Pgc-
1b expression [7], hepatic VLDL-TG production rate was slightly
but non-significantly reduced upon high-fat feeding. Hepatic
VLDL production was thus insufficient to accommodate the
increase in hepatic fatty acid synthesis during high fat feeding,
indicating that there was progressive steatosis in high fat-fed mice.
Moreover, VLDL particle size was reduced in high fat-fed mice
and the relative abundance of apoB48-associated VLDL particles
was increased. The molecular mechanism underlying the de-
creased VLDL-TG secretion rate is not yet clear. We can,
however, conclude from this study that the rate of hepatic fatty
acid synthesis per se does not determine hepatic VLDL-TG
secretion as proposed earlier [20,21,40] and, thus, that VLDL-TG
secretion is not determined by TG availability. Other factors such
as mobilization of the cytosolic TG pool and apoB availability and
–fusion are therefore likely to be important controlling factors in
hepatic VLDL secretion [41–43]. Indeed, the suppression of
VLDL secretion by fish oil has been reported to be due to
increased apoB degradation [44].
In summary, data reported in this study provide insight in a
physiological mechanism that protects the liver from lipotoxicity
under conditions of dietary fatty acid oversupply. Using a novel
MIDA approach we were able to show that high-fat feeding
predominantly promotes fatty acid elongation of pre-existing
palmitate in vivo. Although high-fat feeding resulted in an induction
of hepatic expression of de novo lipogenic genes, we did not observe
a significant increase in the flux through this pathway. Further-
more, cholesterol synthesis was increased, presumably to compen-
sate for increased cholesterol esterification. These physiological
adaptations result in hepatic lipid accumulation and do not occur
if fatty acid influx into the liver is arrested by partial replacement
of saturated fat by fish oil. It should however be noted that the
‘harmless’ storage of excess fatty acids represents the primary
event or the ‘first hit’ in the pathophysiology of NASH [3].
Consequently, such an adaptive physiological response may
eventually predispose to development of liver disease, because it
renders the liver more susceptible to ‘second hits’ [3].
Materials and Methods
Ethics Statement
Experimental procedures were approved by the Ethics Com-
mittee for Animal Experiments of the University of Groningen.
Animals and experimental design
Male C57Bl/6J mice (Charles River, L’Arbresle Cedex,
France), three months of age, were housed in a light- and
temperature-controlled facility (lights on 6:30 AM–6:30 PM,
21uC). They were divided into groups and fed three different diets
for six weeks. All diets were obtained from Abdiets, Woerden, The
Netherlands. One group received normal laboratory chow (RMH-
B), the second group received high-fat diet (beef tallow, which is
rich in saturated fat) and the third group received a diet in which
42% (w/w) of the beef fat was replaced by fish oil (menhaden oil).
For diet composition see Table 1. The fish oil-containing diet was
refreshed three times a week to prevent oxidation. To exclude
acute postprandial effects without the induction of a fasting
response, mice were subjected to a short fasting period of 4 hours
(6–10 AM) prior to all experiments.
Hepatic lipid content and gene expression levels
Mice were sacrificed by cardiac puncture under isoflurane
anaesthesia. Epididymal, perirenal and brown adipose fat pads
were removed and weighed. Livers were quickly removed,
weighed, freeze-clamped and stored at 280uC. Hepatic TG, total
and free cholesterol content were analyzed using commercial
available kits (Roche Diagnostics, Mannheim, Germany and
Wako Chemicals, Neuss, Germany) after lipid extraction [45].
Cholesterol ester concentrations were calculated as the difference
between total and free cholesterol. Hepatic phospholipid content
was determined as described previously [46]. Hepatic fatty acid
composition was analyzed by gas chromatography after trans-
methylation using C17:0 as internal standard [47]. C16 and C18
desaturation indices were calculated from the ratios between
C16:1 n-7 and C16:0 and C18:1 n-7/n-9 and C18:0, respectively.
RNA was extracted from livers using Tri reagent (Sigma-
Aldrich, St. Louis, MO) and converted into cDNA by a reverse
transcription procedure using M-MLV and random primers
according to the manufacturer’s protocol (Sigma-Aldrich). For
quantitative PCR (qPCR), cDNA was amplified using the
appropriate primers and probes. Primer and probe sequences for
18S, acetyl-CoA carboxylase 1/2 (Acc1 and -2), acyl-CoA:choles-
terol acyltransferase (Acat-1 and -2), diacylglycerol acyltransferase
(Dgat1 and 2), glycerol-3-phosphate acyltransferase (Gpat), fatty
acid synthase (Fas), 3-hydroxy-3-methylglutaryl-CoA reductase
(Hmgr), stearoyl-CoA desaturase 1 (Scd1), sterol regulatory element
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LabPediatricsRug.nl). For other primer and probe sequences, see
Table S1. mRNA levels were calculated relative to 18S expression
and normalized for expression levels of control mice on chow.
Determination of de novo lipogenesis, chain elongation
and cholesterol synthesis in vivo
Mice were equipped with a permanent jugular vein catheter
[48] and were allowed a recovery period of 4–5 days. All infusion
experiments were performed in conscious, unrestrained mice. A
0.3 mol/L sodium [1-
13C]-acetate (99 atom %, Isotec/Sigma-
Aldrich) solution was infused at a rate of 0.6 mL/hr during
6 hours. Every hour a blood sample was taken via tail bleeding on
filter paper to determine fractional cholesterol synthesis rates. At
the end of the infusion period, animals were sacrificed by cardiac
puncture. Livers were quickly removed, freeze-clamped and stored
at 280uC. Liver homogenates were prepared in PBS and C17:0
was added as internal standard. Lipids were hydrolyzed in HCl/
acetonitrile (1:22 v/v) for 45 minutes at 100uC. Fatty acids were
extracted in hexane and derivatized for 15 minutes at room
temperature using Br-2,3,4,5,6-pentafluorobenzyl/acetonitrile/tri-
ethanolamine (1:6:2 v/v). Derivatization was stopped by adding
HCl and fatty acid-PFB derivatives were extracted in hexane.
Total cholesterol was extracted from blood spots using ethanol/
acetone (1:1 v/v). Unesterified cholesterol from blood spots was
subsequently derivatized using N,O-bis-(trimethyl)trifluoroaceta-
mide with 1% trimethylchlorosilane at room temperature.
The fatty acid-PFB isotopomer patterns were analyzed using an
Agilent 5975 series GC/MSD (Agilent Technologies, Santa Clara,
CA). Gas chromatography was performed using a ZB-1 column
(Phenomenex, Torrance, CA). Mass spectrometry analysis was
performed by electron capture negative ionization using methane
as moderating gas. Cholesterol-TMS isotopomer patterns were
analyzed using a Trace MS plus GC-MS (Interscience, Breda, The
Netherlands). Gas chromatography was performed using a DB-17
column (J&W Scientific, Falson, CA). Mass spectrometry analysis
was performed in the electron impact mode.
The normalized mass isotopomer distributions measured by
GC-MS (m0–mx) were corrected for natural abundance of
13Cb y
multiple linear regression as described by Lee et al. [49] to obtain
the excess fractional distribution of mass isotopomers (M0–Mx) due
to incorporation of the infused labelled compound, i.e., [1-
13C]-
acetate. This distribution was used in mass isotopomer distribution
analysis (MIDA) algorithms to calculate isotope incorporation and
dilution according to Hellerstein et al. [14–16] in order to
determine fractional palmitate synthesis rates. In short, incorpo-
ration of [1-
13C]-acetate into palmitate was assumed to solely
result from de novo lipogenesis via the malonyl-CoA/FAS pathway.
The measured M1 and M3 isotopomers of palmitate were used to
calculate the acetyl-CoA precursor pool enrichment (pacetate) and
fractional palmitate synthesis (fC16:0).
Stearate is synthesized by chain elongation of de novo synthesized
and/or pre-existing palmitate. The M1 mass isotopomer of
stearate represents the sum of these two processes, while the M3
mass isotopomer solely results from chain elongation of labelled
palmitate. The following approach was used to calculate fractional
stearate and oleate synthesis. We assumed that the acetate
enrichment used for elongation of palmitate equals pacetate.
Stearate generated from de novo synthesized palmitate was
consequently considered as a nonamer of acetate. Therefore, we
applied MIDA algorithms using M3(stearate) and pacetate to
calculate fractional stearate synthesis from elongation of de novo
synthesized palmitate (fstearate(palmitate*)). Total M1(stearate) was
subsequently corrected for the contribution of single labelled
stearate originating from elongation of de novo synthesized
palmitate M1(stearate(palmitate*)) to obtain the contribution of
single labelled stearate originating from elongation of pre-existing
palmitate M1(stearate(palmitate)). Since we assumed that pacetate
represents the precursor pool enrichment of acetate used in
elongation of pre-existing palmitate, the contribution of elongation
of pre-existing palmitate to stearate synthesis fstearate(palmitate) could
finally be calculated.
fstearate palmitate  ðÞ ~M3 stearate ðÞ =F3 stearate ðÞ
in which F3(stearate) equals the theoretical undiluted frequency of
triple labelled stearate at pacetate.
F3 stearate ðÞ ~
9 ðÞ !
9{3 ðÞ ! 3 ðÞ !
pacetate ðÞ
3 1{pacetate ðÞ
9{3
M1(stearate(palmitate*) is calculated according to:
M1 stearate palmitate  ðÞ ðÞ ~fstearate palmitate  ðÞ   F1 stearate ðÞ
in which F1(stearate) equals the theoretical undiluted frequency of
single labelled stearate at pacetate.
F1 stearate ðÞ ~
9 ðÞ !
9{1 ðÞ ! 1 ðÞ !
pacetate ðÞ
1 1{pacetate ðÞ
9{1
Consequently:
M1 stearate palmitate ðÞ ðÞ ~
M1 stearate ðÞ {M1 stearate palmitate  ðÞ ðÞ
in which M1(stearate) represents the measured total M1 mass
isotopomer in stearate.
And finally:
fstearate palmitate ðÞ ~M1 stearate palmitate ðÞ ðÞ =pacetate
Oleate is synthesized by desaturation of stearate via SCD1
activity. We used the measured M1 and M3 isotopomers of oleate
to calculate the fractional contributions of chain elongation of de
novo synthesized and pre-existing palmitate to stearate as a direct
precursor for oleate (foleate(palmitate*) and foleate(palmitate), respectively)
using similar equations to that of stearate
foleate palmitate  ðÞ ~M3 oleate ðÞ =F3 oleate ðÞ
in which F3(oleate) equals the theoretical undiluted frequency of
triple labelled oleate, calculated as for stearate using pacetate.
M1 oleate palmitate  ðÞ ðÞ ~foleate palmitate  ðÞ   F1 oleate ðÞ
in which M1(oleate(palmitate*)) represents the contribution of
elongation of de novo synthesized palmitate to M1(oleate) and
F1(oleate) equals the theoretical undiluted frequency of single
labelled oleate, calculated as for stearate using pacetate.
M1 oleate palmitate ðÞ ðÞ ~M1 oleate ðÞ {M1 oleate palmitate  ðÞ ðÞ
in which M1(oleate(palmitate)) represents the contribution of
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foleate palmitate ðÞ ~M1 oleate palmitate ðÞ ðÞ =pacetate
Fractional cholesterol synthesis was calculated on regular time
points during isotope infusion (ft) by MIDA. From this, fractional
cholesterol synthesis at infinite time (f‘) was calculated using
SAAM II software (version 1.2.1 Saam Institute, University of
Washington) and the following formula:
ft~f? 1{e{kt 
in which k represents the rate constant.
In vivo VLDL-TG production
Mice were injected intraperitoneally with Poloxamer 407
(1 mg/kg body weight) as a 50 mg/mL solution in saline as
previously described [50]. Blood samples were drawn by retro-
orbital bleeding into heparinized tubes at 0, 30, 120, and 240 min
after injection. Immediately after the last blood draw, animals
were sacrificed by cardiac puncture under isoflurane anaesthesia.
Blood was centrifuged (10 minutes, 40006g) to obtain plasma.
Plasma TG levels and TG production rates were determined as
described [50]. Nascent VLDL (d,1.006) was isolated from the
final plasma sample of each animal using a Optima TM LX
tabletop ultracentrifuge (Beckman Instruments Inc., Palo Alto,
CA) at 108,000 rpm for 125 minutes.
VLDL composition and particle size
VLDL-TG and cholesterol contents were determined as
described [50]. Phospholipid content was determined using a
commercial kit (Wako Chemicals). VLDL particle diameter was
estimated according to Fraser et al. [51]. VLDL particle volume
was subsequently derived from its diameter. Apolipoprotein B
(apoB) content of nascent VLDL particles was determined using
Western Blot as previously described [52]. Four representative
VLDL samples per group were analyzed and equal amounts of
total lipid were loaded onto the gel. Signal intensity was quantified
using a Molecular Imager (ChemiDoc XRS System, Bio-Rad
Laboratories, Hercules, CA) and the relative abundance of
apoB48 versus apoB100-associated particles was calculated.
Statistics
All data are presented as means6SEM. Statistical analysis was
performed using Brightstat software (www.brightstat.com). Anal-
ysis of two groups (chow vs. high-fat, high-fat vs. high-fat/fish oil)
was assessed by Kruskal-Wallis using the Conover test for post-hoc
analysis. Statistical significance was reached at a p value below
0.05.
Supporting Information
Table S1 Primer and probe sequences used for quantitative
PCR.
Found at: doi:10.1371/journal.pone.0006066.s001 (0.03 MB
DOC)
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